文献速递脊柱外科

脊柱手术局部伤口浸润吗啡与酮咯酸镇痛无差异:随机对照试验

No Difference in Pain After Spine Surgery with Local Wound Filtration of Morphine and Ketorolac: A Randomized Controlled Trial.
PubMed 文献 · Clin Orthop Relat Res · 2020-01-01

这项随机双盲对照试验纳入80例腰椎椎间融合术患者,比较标准布比卡因+肾上腺素伤口浸润与加入酮咯酸30mg和吗啡5mg的多模式浸润。结果显示多模式组在VAS疼痛评分上未达到临床重要差异(MCID 2cm),但吗啡消耗量略低且阿片相关副作用(恶心呕吐)更少。作者不建议临床常规使用该多模式浸润方案。

要点

  • 多模式伤口浸润未使VAS疼痛评分降低达到MCID(2cm)。
  • 多模式组术后吗啡消耗量略低于对照组(0.3±1.0 vs 2.8±2.8)。
  • 多模式组恶心呕吐发生率低于对照组(3% vs 30%)。

核心结论

  • 多模式伤口浸润(布比卡因+酮咯酸+吗啡+肾上腺素)未产生临床重要的疼痛缓解或阿片消耗减少。
  • 鉴于无实质获益且存在阿片类药物和非甾体抗炎药潜在风险,不建议临床常规使用该方案。

研究设计与样本

  • 随机、对照、双盲试验,纳入80例成人腰椎椎间融合术患者,随机分为对照组(n=40)和多模式组(n=40)。
  • 对照组伤口浸润0.5%布比卡因100mg(20mL)+肾上腺素0.5mg(0.5mL);多模式组浸润0.5%布比卡因92.5mg(18.5mL)+酮咯酸30mg(1mL)+吗啡5mg(0.5mL)+肾上腺素0.5mg(0.5mL)。
  • 所有患者、外科医生和研究者均对分组设盲,按意向性治疗原则分析,无失访或方案偏离。

主要发现

  • 多模式组与对照组VAS评分差异在任何时间点均未超过MCID(2cm);最大治疗效应在3小时,仅-1.3cm(3.2±1.8 vs 4.5±1.9,95%CI -1.3至-0.3,p<0.001)。
  • 对照组吗啡消耗量略高于多模式组(2.8±2.8 vs 0.3±1.0,平均差2.47,p<0.001)。
  • 多模式组恶心呕吐发生率低于对照组(3%[1/40] vs 30%[12/40],p=0.001),所有副作用均为暂时性且无严重事件。

关键数值与推荐

  • 以10cm VAS量表上2cm变化作为最小临床重要差异(MCID)。
  • 疼痛评分差异未超过MCID,视为无临床重要缓解。

临床怎么用

  • 不建议在腰椎椎间融合术患者中常规使用含酮咯酸和吗啡的多模式伤口浸润方案。
  • 应权衡阿片类药物和非甾体抗炎药的潜在风险(如老年患者多重用药、非甾体抗炎药严重不良反应)。

局限性

  • 本研究仅纳入腰椎椎间融合术患者,结论外推需谨慎。
  • 样本量80例,可能不足以检测较小差异。
  • 所有治疗由同一名外科医生实施,可能影响普遍性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Controlling postoperative pain after spinal surgery is important for rehabilitation and patient satisfaction. Wound infiltration with local anesthetics may improve postoperative pain, but true multimodal approaches for achieving analgesia after spinal surgery remain unknown. QUESTIONS/PURPOSES: In this randomized, controlled, double-blind trial after lumbar interbody fusion, we asked: (1) Does multimodal analgesia reduce VAS pain scores by a clinically important amount? (2) Does this analgesic approach reduce the amount of morphine patients consume after surgery? (3) Is this approach associated with fewer opioid-related side effects after surgery? METHODS: This study included 80 adult patients undergoing lumbar interbody fusion who were randomized into two groups: A control group (n = 40) who received infiltration of the surgical incision at the end of the procedure with an injection of 0.5% bupivacaine 100 mg (20 mL) and epinephrine 0.5 mg (0.5 mL), and the multimodal group (n = 40), who received wound infiltration with the same approach but with different medications: 0.5% bupivacaine 92.5 mg (18.5 mL), ketorolac 30 mg (1 mL), morphine 5 mg (0.5 mL), and epinephrine 0.5 mg (0.5 mL). There were no between-group differences in the proportion of patients who were male, nor in the mean age, height, weight, preoperative pain score, or surgical time. All treatments were administered by one surgeon. All patients, the surgeon, and the researchers were blinded to the allocation of patients to each group. Pain at rest was recorded using the VAS. Postoperative morphine consumption (administered using a patient-controlled analgesia pump) and opiod-associated side effects including nausea/vomiting, pruritus, urinary retention, and respiratory depression were assessed; this study was analyzed according to intention-to-treat principles. No loss to follow-up or protocol deviations were noted. We considered a 2-cm change on a 10-cm scale on the VAS as the minimum clinically important difference (MCID). Differences smaller than this were considered unlikely to be important. RESULTS: At no point were there between-group differences in the VAS scores that exceeded the MCID, indicating no clinically important reductions in pain associated with administering multimodal injections. The highest treatment effect was observed at 3 hours that showed only a -1.3 cm mean difference between the multimodal and the control groups (3.2 ± 1.8 versus 4.5 ± 1.9 [95% CI -1.3 to -0.3]; p < 0.001), which was below the MCID. Morphine consumption was very slightly higher in the control group than in the multimodal group (2.8 ± 2.8 versus 0.3 ± 1.0, mean difference 2.47; p < 0.001). The percentage of patients reporting opioid-related side effects was lower in the multimodal group than in the control group. The proportions of nausea and vomiting were higher in the control group (30% [12 of 40] than in the multimodal group (3% [1 of 40]; p = 0.001). All of these side effects were transient and none was severe. CONCLUSIONS: Multimodal wound infiltration with an NSAID and morphine did not yield any clinically important reduction in pain or opioid consumption. Since no substantial benefit of adding these drugs to a patient's aftercare regimen was achieved, and considering the potential risks of administering opioids and NSAIDs (such as, polypharmacy in older patients, serious adverse effects of NSAIDs), we recommend against routine use of this approach in clinical practice. LEVEL OF EVIDENCE: Level I, therapeutic study.

来源:Clin Orthop Relat Res,查看原文。版权归原作者所有。

引用

  1. Singhatanadgige W, Chancharoenchai T, Honsawek S, et al. No Difference in Pain After Spine Surgery with Local Wound Filtration of Morphine and Ketorolac: A Randomized Controlled Trial. Clin Orthop Relat Res. 2020. PMID: 32511143. doi:10.1097/CORR.0000000000001354

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。